Pfizer stock trades in the mid-$26 range as of August 13, 2026, after the drugmaker beat Q2 2026 expectations and nudged full-year revenue guidance higher while keeping EPS targets unchanged.

The credit crunch has not put an end to major acquisitions by well-run companies that have a compelling strategic plan and a pile of cash. New York-based Pfizer, the world’s biggest drug maker, agreed ...

Pfizer stock is trading close to consensus price targets after Q2 2026 results showed a clear earnings and revenue beat, while full-year guidance and dividend yield frame the risk-reward for ...

Pfizer (NYSE: PFE) shares fell more than 6% in pre-market trade on Wednesday after the company offered an outlook for the next year that trailed estimates. Revenue is seen at $60 billion, up or down ...

Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for Pfizer Inc. Use the full market events calendar to scan activity across all tickers.

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) ...

Drug maker Pfizer and the Ireland-based Allergan confirmed reports Monday that they were merging, creating the world’s largest pharmaceutical company with an estimated value of $160 billion. The move ...

Add Yahoo as a preferred source to see more of our stories on Google. PEAPACK-GLADSTONE – The Pfizer corporate campus on Route 206 is being eyed as a site for senior citizens housing. The borough's ...

Late in 2023 I believed that the potential was still there in the case of Pfizer (PFE) after another setback in the pipeline. To see where Pfizer comes from, we really have to create some perspective, ...